Dr. redI of India: the business of winning the bid in China is growing rapidly!
-
Last Update: 2019-11-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Erez Israeli, chief executive of Dr Reddy's, a large pharmaceutical company in India, said recently that the company's business is now growing at a double-digit rate in China and is expected to soar in the near future In the first half of the company's financial performance conference call, Israel described the company's current market strategy and future expansion plan in the Chinese market Israeli stressed that Dr redI has achieved a "milestone victory" in the recent 4 + 7 volume procurement nationwide expansion The company won the bid for olanzapine, an antipsychotic drug, and defeated Lilly's original research drug Zyprexa Israel affirmed the significance of the victory, which made the company "the first Indian generic company to win a new round of bidding in China," and also showed that "the company is trying to make the Chinese market one of the main growth drivers."
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
